Bellevue Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bellevue Group’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-385,014	Closed	-$1.03M	–	175
2022 Q4	$1.03M	Hold	385,014	–	–	0.01%	136
2022 Q3	$1.1M	Hold	385,014	–	–	0.02%	133
2022 Q2	$1.91M	Hold	385,014	–	–	0.03%	130
2022 Q1	$2.74M	Hold	385,014	–	–	0.03%	128
2021 Q4	$7M	Hold	385,014	–	–	0.07%	116
2021 Q3	$7.53M	Hold	385,014	–	–	0.08%	123
2021 Q2	$17.3M	Buy	385,014 +6,011	+2%	+$279K	0.17%	112
2021 Q1	$19M	Buy	379,003 +218,498	+136%	+$14.9M	0.2%	101
2020 Q4	$14.4M	Buy	160,505 +52,995	+49%	+$4.46M	0.16%	107
2020 Q3	$8.21M	Buy	+107,510	New	+$6.83M	0.11%	113

Other funds holding CELL

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bellevue Group's CELL Position: Q1 2023 in Review

Bellevue Group sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 385,014 shares — an estimated $1.03M sold.

Bellevue Group first reported a position in CELL in Q3 2020 and held it in 10 quarters. The position peaked at $19M in Q1 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

Bellevue Group reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bellevue Group sold 385,014 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $1.03M.
Bellevue Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Bellevue Group's PhenomeX Inc. Common Stock position peaked at $19M in Q1 2021.
102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Bellevue Group's 13F filing for Q1 2023, filed 15 May 2023.